Financials

  • Market Capitalization 765 M
  • Employee 29
  • Founded 2018
  • CEO N/A
  • Website www.climbbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZNKL0K6
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.55
Relación precio/flujo de caja
-932.13

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2637
ZVRA
Zevra Therapeutics, Inc. - Common Stock
13.21 USD+0.23%-8.07%+3.12%+24.15%780.91 M USD
2642
RIGL
Rigel Pharmaceuticals, Inc. - Common Stock
41.52 USD+0.53%+0.31%+24.91%+37.80%768.21 M USD
2658
AURA
Aura Biosciences, Inc. - Common Stock
7.22 USD+3.14%+4.18%+11.42%+6.18%746.45 M USD
2663
OMER
Omeros Corporation - Common Stock
10.48 USD+4.70%+3.25%+18.82%+164.65%758.49 M USD